title: [Immunochemical properties of short recombinant polypeptides of proteine of, the West Nile virus bearing epitopes of domains I and II].
abstract: Fragments cDNA (nt 935-1475, 1091-1310, 935-1193) encoding N-terminal part of protein E of West Nile virus (WNV), strain LEIV-Vlg99-27889-human were obtained and cloned. Recombinant polypeptides of glycoprotein E (E1-86, E53-126, E1-180) of the WNV with corresponding amino acid sequence to the cloned fragments of cDNA and modeling the epitopes of domains I and II of surface glycoprotein E were purified by affinity chromatography. Twelve types of monoclonal antibodies (MAbs) created in our laboratory against recombinant polypeptide E1-180 interact with glycoprotein E of the WNV as results of Western blot and ELISA that is demonstrating an similarity of chemical structure of short recombinant polypeptides and corresponding amino acid sequence regions of WNV protein E. Analysis of interactions of MAbs with short recombinant polypeptides and protein E of tick-borne encephalitis virus let us reveal no less than six epitopes within domains I and II of glycoprotein E of the WNV. No less than seven types of MAbs to 86-126 aa region of the domain II were found where located peptide providing fusion of virus--cell membranes (98-110 aa). The epitope for anti-receptor MAbs 10H10 within 53-86 aa region of domain II of protein E of the WNV was mapped and it shows that the fusion peptide and co-receptor of protein E for cellular laminin-binding protein (LBP) are spatial nearness. X-ray model of protein E let us suppose that bc-loop (73-89 aa) of domain II interacts with LBP and together with cd-loop (fusion peptide) determines an initial stages of penetration virions into cell.
authors.forename: M V
authors.initials: MV
authors.lastname: Bogachek
authors.forename: E V
authors.initials: EV
authors.lastname: Protopopova
authors.forename: V A
authors.initials: VA
authors.lastname: Ternovoĭ
authors.forename: A V
authors.initials: AV
authors.lastname: Kachko
authors.forename: A V
authors.initials: AV
authors.lastname: Ivanova
authors.forename: V A
authors.initials: VA
authors.lastname: Ivanisenko
authors.forename: V B
authors.initials: VB
authors.lastname: Loktev
mesh_terms: D000595:Amino Acid Sequence; D000911:Antibodies, Monoclonal / Q000276:immunology; D000914:Antibodies, Viral / Q000276:immunology; D002478:Cells, Cultured; D003001:Cloning, Molecular; D018604:Epitope Mapping; D006023:Glycoproteins / Q000096:biosynthesis / Q000737:chemistry / Q000276:immunology*; D006801:Humans; D007120:Immunochemistry; D016056:Immunodominant Epitopes / Q000276:immunology*; D008969:Molecular Sequence Data; D010455:Peptides / Q000737:chemistry / Q000235:genetics / Q000276:immunology*; D017434:Protein Structure, Tertiary; D011994:Recombinant Proteins / Q000096:biosynthesis / Q000737:chemistry / Q000276:immunology; D014764:Viral Proteins / Q000096:biosynthesis / Q000737:chemistry / Q000276:immunology*; D014902:West Nile virus / Q000235:genetics / Q000276:immunology* / Q000378:metabolism
chemical_list: D000911:Antibodies, Monoclonal; D000914:Antibodies, Viral; D006023:Glycoproteins; D016056:Immunodominant Epitopes; D010455:Peptides; D011994:Recombinant Proteins; D014764:Viral Proteins